MicroDose is actively seeking partnerships and licensing opportunities for all three of its drug delivery technology platforms, as follows: 

Pulmonary Delivery

• Licensing and/or co-development of the MicroDose Electronic Dry Powder Inhaler for the delivery of small and large molecule therapeutics for both local and systemic applications in all therapeutic areas

Combination Oral Dosage

• Licensing and/or co-development of MicroDose's patented fixed-dose combination oral dosage technology for use with partner compounds
• Licensing or co-marketing or purchase of fixed-dose combination drug products currently under development by MicroDose

Needlefree Injection

• License or purchase or co-development of MicroDose's patented needlefree injection system approaches

Please visit our User Agreement. Your continued use of this site will automatically constitute your agreement to be bound by all the terms and conditions of the User Agreement.

©2004 MicroDose Technologies, Inc.